{"nct_id":"NCT04091126","title":"Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2019-12-18","start_date_type":"ACTUAL","primary_completion_date":"2025-06-02","primary_completion_date_type":"ACTUAL","completion_date":"2026-12-31","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["GSK"]}